Claudin18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers

Download slides, review a text module, listen to a podcast, and read an expert commentary on the rationale and clinical development of therapies targeting claudin18.2 for patients with gastric and GEJ cancers.

Share

Program Content

Activities

Claudin18.2 in G/GEJ: Module
Claudin18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2023

Expires: April 24, 2024

Claudin18.2 in G/GEJ: Slides
Claudin18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2023

Activities

Claudin 18.2 in Gastric Cancer
Experts Discuss Claudin 18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 28, 2023

Activities

Claudin18.2 in Gastric Cancer
Considering a Claudin18.2-Targeted Agent in the Current Treatment Landscape for HER2-Negative Gastric Cancers
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 14, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Astellas and Bristol Myers Squibb.

Astellas

Bristol Myers Squibb